CT and nuclear medicine in screening for neurological disease

Unit costs of computerized tomography (CT) in Australian hospital practice are considerably lower than those reported in the United States' literature, and not significantly higher than those of nuclear brain scanning which is at a threefold to fourfold disadvantage in false negative rates. CT is cost-effective not only in defining but in screening for neurological disease, and should replace radionuclide scans in both roles.